July 3, 2018  – By Francine McKenna, Reporter MiMedx Group, Inc. played a version of, “Can you top that?” on Monday, when the troubled biopharmaceutical company installed an interim CEO and a new board chairman following the latest wave of executive departures. The company’s stock MDXG, -8.37%  tumbled 38% on the news, sending it to its lowest level since September, […]